Fair 84°
News
COVID-19: Pfizer Seeks Federal Approval To Market Vaccine Directly To Consumers COVID-19: Pfizer Seeks Federal Approval To Market Vaccine Directly To Consumers
Covid-19: Pfizer Seeks Federal Approval To Market Vaccine Directly To Consumers Pfizer and European partner company BioNTech are seeking full approval from the federal government to market their two-dose COVID-19 vaccine directly to people age 16 and over, as well as businesses and schools. The vaccine has been available in the United States since mid-December under an Emergency Use Authorization waiver by the Food and Drug Administration. Since then, the companies have delivered more than 170 million doses of the vaccine across the United States. “We are proud of the tremendous progress we’ve made since December in delivering vaccines to millions of Americans, in col…

SHARE

by Joe Lombardi
Business
COVID-19: Pfizer Nearing Release Of Vaccine For New Age Group Of Children, FDA Says COVID-19: Pfizer Nearing Release Of Vaccine For New Age Group Of Children, FDA Says
Covid-19: Pfizer Nearing Release Of Vaccine For New Age Group Of Children, FDA Says The US Food and Drug Administration could authorize Pfizer's COVID-19 vaccine for children ages 12 to 15 as early as next week, The New York Times reported on Monday, May 3, citing federal officials.  The timing could not be better for school districts that are resuming in-person instruction and hoping for a full return to normalcy next fall.  Vaccinating children is also a crucial element in achieving herd immunity and decreasing numbers of hospitalizations and deaths, The Times says.  While NJ, NY and CT positive rates have been dropping, other states including Pennsylvani…

SHARE

by Jon Craig
News
COVID-19: Moderna Announces How Long Vaccine Can Be Stored, How Many Doses It Will Make In 2022 COVID-19: Moderna Announces How Long Vaccine Can Be Stored, How Many Doses It Will Make In 2022
Covid-19: Moderna Announces How Long Vaccine Can Be Stored, How Many Doses It Will Make In 2022 New data has found that the Moderna COVID-19 vaccine vials will maintain its efficacy and stability for several months if it is properly stored at temperatures found in refrigerators. Currently, the vaccine is approved to be stored in a refrigerator between 36 and 46 degrees Fahrenheit for up to 30 days and up to seven months at minus 4 Fahrenheit. However, new data from Moderna found that it could support a three-month refrigerated shelf life that could “facilitate easier distribution to doctor’s offices and other smaller settings” if authorized by the Food and Drug Administration (FDA). …

SHARE

by Zak Failla
Schools
COVID-19: SUNY Campuses Unveil Masking Guidelines COVID-19: SUNY Campuses Unveil Masking Guidelines
Covid-19: SUNY Campuses Unveil Masking Guidelines The State University of New York will be relaxing its mask policies to match the new guidance that was released by the Centers for Disease Control and Prevention (CDC). The CDC announced on Tuesday, April 27 that people who are fully vaccinated - one shot of Johnson & Johnson or two doses of Pfizer or Moderna - will no longer have to wear masks while gathering in small groups outside. Earlier story - COVID-19: CDC Announces Major New Guidance On Mask Wearing In response, SUNY Chancellor Jim Malatras says that moving forward, the same rules will apply to both students and staff on its…

SHARE

by Zak Failla
News
COVID-19: Brand-New Data On Number Of Breakthrough Cases Among Fully Vaccinated Released By CDC COVID-19: Brand-New Data On Number Of Breakthrough Cases Among Fully Vaccinated Released By CDC
Covid-19: Brand-New Data On Number Of Breakthrough Cases Among Fully Vaccinated Released By CDC The Centers for Disease Control and Prevention (CDC) has just released brand-new data on the percentage of people who have become infected with COVID-19 despite being fully vaccinated  The latest info shows that the number remains extremely low. In those totals, released on Friday, April 30, more than 95 million Americans were fully vaccinated as of Monday, April 26.  To be fully vaccinated, two weeks or more must have passed since they received the second dose of the Pfizer or Moderna vaccine or the single-dose Johnson & Johnson vaccine. Of those nearly 100 million ful…

SHARE

by Joe Lombardi
News
COVID-19: Results Of New Federal Study On Vaccine Effectiveness Released COVID-19: Results Of New Federal Study On Vaccine Effectiveness Released
Covid-19: Results Of New Federal Study On Vaccine Effectiveness Released A new study from the Centers for Disease Control and Prevention (CDC) has found that the COVID-19 vaccine has proven effective in preventing hospitalizations among older adults who are fully vaccinated. According to the CDC, the Pfizer and Moderna COVID vaccines are 94 percent effective in adults ages 65 and older who have received both doses of the shot and allowed 14 days to pass after the second dose. The study, which followed more than 400 hospitalized adults across 14 states from January to March, also found that the two-dose vaccines are 64 percent effective in the elderly who have o…

SHARE

by Zak Failla
News
COVID-19: NY Adopts New CDC Guidance On Mask Wearing COVID-19: NY Adopts New CDC Guidance On Mask Wearing
Covid-19: NY Adopts New CDC Guidance On Mask Wearing New York will be adopting the new, more flexible mask-wearing guidance that has been provided by the Centers for Disease Control & Prevention (CDC). The CDC announced on Tuesday, April 27 that people who are fully vaccinated - one shot of Johnson & Johnson or two doses of Pfizer or Moderna - will no longer have to wear masks while gathering in small groups outside. Earlier story - COVID-19: CDC Announces Major New Guidance On Mask Wearing During a COVID-19 briefing later that day in Johnson City, New York Gov. Andrew Cuomo confirmed that the state will be following that guidance an…

SHARE

by Zak Failla
Politics
COVID-19: CDC Announces Major New Guidance On Mask Wearing COVID-19: CDC Announces Major New Guidance On Mask Wearing
Covid-19: CDC Announces Major New Guidance On Mask Wearing The Centers for Disease Control & Prevention (CDC) has just released major new guidance on mask-wearing amid the COVID-19 pandemic. Under the new guidance, announced Tuesday afternoon, April 27, people who are fully vaccinated and who are outdoors no longer have to wear masks if they are gathered in small groups. Masks should still be worn at heavily attending outdoor gatherings, including concerts and sports events, where social distancing is not possible, the CDC said. It is also safe for those fully vaccinated to return to several activities inside, including attending religious ser…

SHARE

by Joe Lombardi
News
COVID-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says COVID-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says
Covid-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says New studies have found that Americans receiving the first dose of the two-shot Moderna and Pfizer COVID-19 vaccine may be protected against the spread of the vaccine. According to a Bloomberg report, out of more than 1,000 staff members tested at Cedars-Sinai Medical Center in Los Angeles, many responded to the first dose so robustly that their results were similar to co-workers who received both doses. Research leader Susan Cheng, who co-authored a study published in the Nature Medicine journal, said that those who have already contracted the virus, immune responses after one vaccine have …

SHARE

by Zak Failla
News
COVID-19: Pill Being Touted As Potential Cure For Virus Could Be Coming COVID-19: Pill Being Touted As Potential Cure For Virus Could Be Coming
Covid-19: Pill Being Touted As Potential Cure For Virus Could Be Coming An anti-viral pill that's being touted as a potential cure for COVID-19 could be ready later this year, according to a brand-new report. PF-07321332, an antiviral drug being developed by Pfizer, is designed to attack the “spine” of the COVID-19 virus to prevent it from replicating in the nose, throat, and lungs, according to the Telegraph. Trials involving volunteers from age 18 to 60 are now underway at Pfizer facilities in both the United States and Europe, according to the report. Pizer's director of medicinal chemistry, Dafydd Owen, said the pill was developed from scratch, the Te…

SHARE

by Joe Lombardi
News
COVID-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women COVID-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women
Covid-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women Results of the largest study conducted by the Centers for Disease Control and Prevention (CDC) on the use of two-dose COVID-19 vaccines by pregnant women have been released. The new study, published this week in the New England Journal of Medicine, found that out of more than 35,000 people who were pregnant or soon to become pregnant, there is no evidence to suggest that the Pfizer or Moderna COVID vaccines pose risk during pregnancy. Little data has been released on the Johnson & Johnson one-dose vaccine, which had run into production issues before distribution was paused following rep…

SHARE

by Zak Failla
News
COVID-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says COVID-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says
Covid-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says The Centers for Disease Control & Prevention (CDC) has released the first data on so-called "breakthrough" COVID-19 cases, meaning those who have become infected despite being fully vaccinated. So far, there have been about 5,800 such cases, the CDC told CNN.  At the time that data was collected, 77 million American adults had been fully vaccinated, meaning 99.992 percent had dodged the disease. The efficacy rates of the double-dose Pfizer and Moderna vaccines are both around 95 percent. "To date, no unexpected patterns have been identified in case demographics or vaccine ch…

SHARE

by Joe Lombardi